Evidence map›Paper›PMID 41732159›Full record

ArticleFrontiers in genetics2026

Possible link between the apparently pathogenic

Mariusz Berdyński, Małgorzata Borczyk, Kinga Humińska-Lisowska, Michał Korostyński, Paweł Cięszczyk, Cezary Żekanowski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mariusz BerdyńskiDepartment of Neurogenetics and Functional Genomics, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
Małgorzata BorczykLaboratory of Pharmacogenomics, Department of Molecular Neuropharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Kinga Humińska-LisowskaFaculty of Physical Education, Gdansk University of Physical Education and Sport, Gdansk, Poland.
Michał KorostyńskiLaboratory of Pharmacogenomics, Department of Molecular Neuropharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Paweł CięszczykFaculty of Physical Education, Gdansk University of Physical Education and Sport, Gdansk, Poland.
Cezary ŻekanowskiDepartment of Neurogenetics and Functional Genomics, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Athletic performance is a multifactorial trait influenced by both genetic and environmental factors. Evolutionary pressure can lead to seemingly contradictory effects of genetic mutations, and carriers of deleterious mutations may exhibit advantages. The objective of our exploratory study was to identify rare deleterious variants influencing athletic success. A total of 101 top-elite Polish athletes were recruited for the whole-genome sequencing analysis. We identified a variant in the

Indexed as

elite athletesFanconi anemiagenetic predispositiongenomic variantmutation

Identifiers

PMID41732159
PMCPMC12925683

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.